198 related articles for article (PubMed ID: 9651906)
1. Effect of a HMG-CoA reductase inhibitor combined with hormone replacement therapy on lipid metabolism in Japanese women with hypoestrogenic lipidemia: a multicenter double-blind controlled prospective study.
Ohta H; Komukai S; Sugimoto I; Fuyuki T; Makita K; Takamatsu K; Horiguchi F; Nozawa S
Maturitas; 1998 Jun; 29(2):163-71. PubMed ID: 9651906
[TBL] [Abstract][Full Text] [Related]
2. A comparison of continuous combined hormone replacement therapy, HMG-CoA reductase inhibitor and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Ozsener S; Sendag F; Koc T; Terek MC; Oztekin K; Bilgin O
J Obstet Gynaecol Res; 2001 Dec; 27(6):353-8. PubMed ID: 11794823
[TBL] [Abstract][Full Text] [Related]
3. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial.
Sponseller CA; Morgan RE; Kryzhanovski VA; Campbell SE; Davidson MH
Clin Ther; 2014 Aug; 36(8):1211-22. PubMed ID: 24998014
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of HMG-CoA reductase inhibitor in Japanese hyperlipidemic women within seven years of menopause.
Ohta H; Masuda A; Fuyuki T; Sugimoto I; Suda Y; Makita K; Takamatsu K; Horiguchi F; Nozawa S
Horm Res; 2000; 53(3):120-4. PubMed ID: 11044791
[TBL] [Abstract][Full Text] [Related]
6. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
[TBL] [Abstract][Full Text] [Related]
7. Menopause and hyperlipidemia: pravastatin lowers lipid levels without decreasing endogenous estrogens.
Honjo H; Tanaka K; Urabe M; Naitoh K; Ogino Y; Yamamoto T; Okada H
Clin Ther; 1992; 14(5):699-707. PubMed ID: 1345259
[TBL] [Abstract][Full Text] [Related]
8. Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile.
Dangas G; Badimon JJ; Smith DA; Unger AH; Levine D; Shao JH; Meraj P; Fier C; Fallon JT; Ambrose JA
J Am Coll Cardiol; 1999 Apr; 33(5):1294-304. PubMed ID: 10193730
[TBL] [Abstract][Full Text] [Related]
9. Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?
Heikkinen AM; Niskanen L; Ryynänen M; Komulainen MH; Tuppurainen MT; Parviainen M; Saarikoski S
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):402-7. PubMed ID: 9974425
[TBL] [Abstract][Full Text] [Related]
10. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
Nerbrand C; Nyberg P; Nordström L; Samsioe G
Maturitas; 2002 May; 42(1):55-62. PubMed ID: 12020980
[TBL] [Abstract][Full Text] [Related]
11. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.
Albert MA; Danielson E; Rifai N; Ridker PM;
JAMA; 2001 Jul; 286(1):64-70. PubMed ID: 11434828
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
Vigna GB; Donegà P; Zanca R; Barban A; Passaro A; Pansini F; Bonaccorsi G; Mollica G; Fellin R
Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
[TBL] [Abstract][Full Text] [Related]
13. Pitavastatin 4 mg Provides Significantly Greater Reduction in Remnant Lipoprotein Cholesterol Compared With Pravastatin 40 mg: Results from the Short-term Phase IV PREVAIL US Trial in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia.
Miller PE; Martin SS; Joshi PH; Jones SR; Massaro JM; D'Agostino RB; Sponseller CA; Toth PP
Clin Ther; 2016 Mar; 38(3):603-9. PubMed ID: 26922296
[TBL] [Abstract][Full Text] [Related]
14. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
15. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy.
Heikkinen AM; Tuppurainen MT; Niskanen L; Komulainen M; Penttilä I; Saarikoski S
Eur J Endocrinol; 1997 Nov; 137(5):495-502. PubMed ID: 9405029
[TBL] [Abstract][Full Text] [Related]
16. Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with type 2 diabetes mellitus.
Rustemeijer C; Schouten JA; Voerman HJ; Hensgens HE; Donker AJ; Heine RJ
Diabetes Metab Res Rev; 2000; 16(2):82-7. PubMed ID: 10751747
[TBL] [Abstract][Full Text] [Related]
17. A novel concept to preserve the beneficial effects of hormone replacement therapy in bilaterally female ovariectomized rats: role of lovastatin therapy.
El-Swefy SE; Asker ME; Ali SI; Mohammed HE
Pharmacol Res; 2002 Mar; 45(3):167-73. PubMed ID: 11884211
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety of pravastatin-gemfibrozil therapy in mixed hyperlipidemia.
Iliadis EA; Rosenson RS
Clin Cardiol; 1999 Jan; 22(1):25-8. PubMed ID: 9929751
[TBL] [Abstract][Full Text] [Related]
19. Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.
Eriksson M; Hådell K; Holme I; Walldius G; Kjellström T
J Intern Med; 1998 May; 243(5):373-80. PubMed ID: 9651560
[TBL] [Abstract][Full Text] [Related]
20. Estrogen/progesterone replacement versus pravastatin and their sequential association in hypercholesterolemic postmenopausal women.
Lemay A; Dodin S; Turcot L; Déchêne F; Forest JC
Maturitas; 2001 Dec; 40(3):247-57. PubMed ID: 11731186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
